Argon Medical Acquires SeQure and DraKon Microcatheters From Guerbet

January 14, 2025—Argon Medical announced it has acquired the SeQure and DraKon Microcatheters from Guerbet SA, along with certain assets from Accurate Medical Therapeutics, Ltd.

The acquisition adds therapeutic devices and accessories to Argon's oncology portfolio, which previously comprised diagnostic and biopsy devices. The company highlighted the navigability and broad compatibility of the devices, as well as the SeQure reflux control microcatheter's ability create a fluid barrier to direct the flow of therapeutic agents and devices to the intended target.

“A microcatheter can make or break a procedure,” commented Neal Khurana, MD, in the company's announcement. “A well-designed microcatheter determines whether you achieve precise navigation, efficient delivery of embolic materials, and ultimately, optimal patient outcomes. The DraKon and SeQure microcatheters have become preferred tools in my practice due to their dependable trackability through tortuous vessels, the performance of their hydrophilic coating, and their ability to deliver contrast and embolics efficiently, even through the smallest catheter sizes.”

Argon plans to transition manufacturing of the catheters to its primary manufacturing facility in Athens, Texas, and to re-commercialize the devices in all markets they were previously available while evaluating new market opportunities.